US.IDXX · Idexx Laboratories

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.224124721603564,
        "turnoverUsdM": 273.96352375,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.IDXX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 536.2842,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.4,
      "take_profit_price": 589.3125,
      "target_multiplier": 1.9,
      "technical_strength": 1.75,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.448249443207128,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 83.3,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 76.3,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 537.2615,
    "ma50": 533.6936,
    "close": 561.25,
    "prevClose": 570.21,
    "avgVolume20": 517357,
    "volumeRatio": 0.94,
    "changePercent": -1.57
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": 0.005950585305514844,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 0.9290743155149935,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.6882953193608122,
      "volat_points": 0,
      "day_range_pct": 0.015171296213808529,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 83.3,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 90,
        "contribution": 4.5
      },
      {
        "raw": 14,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 70,
        "contribution": 14
      },
      {
        "raw": 10.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 70.67,
        "contribution": 10.6
      },
      {
        "raw": 10,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 21.8,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 72.67,
        "contribution": 21.8
      },
      {
        "raw": 8,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 80,
        "contribution": 8
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "謹慎買入",
    "result": 76.3,
    "details": [
      "基本面分析總分: 4.5/5分",
      "資金流分析總分: 14/20分",
      "市場環境分析總分: 10.6/15分",
      "催化劑分析: 10/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 21.8/30分",
      "情緒分析: 8/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 10,
      "基本面": 4.5,
      "資金流": 14,
      "市場環境": 10.6,
      "情緒分析": 8,
      "技術信號": 21.8,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 10,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "catalystCount": 2
            }
          },
          "catalystPoints": 10
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0.75,
          "roePoints": 0.75,
          "debtPoints": 0.4,
          "marginPoints": 0.75,
          "turnoverUsdM": 273.96352375,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 3.2,
          "obvPoints": 2.4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.IDXX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.39
            }
          },
          "trend": {
            "score": 1.7999999999999998,
            "details": {
              "qqq": {
                "ma20": 733.18400235,
                "ma50": 725.2621992000002,
                "name": "QQQ",
                "close": 721.23999,
                "points": 0.4
              },
              "spy": {
                "ma20": 770.4114959000001,
                "ma50": 767.5287948999999,
                "name": "SPY",
                "close": 769.65997,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.224124721603564,
          "atrPoints": 3,
          "cciPoints": 4,
          "vixPoints": 1.8,
          "marketTrendPoints": 1.7999999999999998
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "優秀",
        "items": {
          "sentiment": {
            "score": 8,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 143200587,
                "url": "https://finnhub.io/api/news?id=1d076e9f7ff5612c6f6c0677e3b7890c25cfe4d5a892792ddac12c66fb450509",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1793019612,
                "headline": "Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 143104276,
                "url": "https://finnhub.io/api/news?id=12dec2da51e73e3d58d1875772428842d2100dc7e0c4ca0a1127faa2465f0df9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Is IDXX a good stock to buy? We came across a bullish thesis on IDEXX Laboratories, Inc. on Astute Optics – US’s Substack. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.’s share was trading at $553.48 as of October 21st 2026. IDXX’s trailing and forward P/E were 36.65 and 31.45 respectively […]",
                "category": "company",
                "datetime": 1792700301,
                "headline": "IDEXX Laboratories (IDXX) vs. ZTS and NEOG: Can Raised Guidance and Product Expansion Drive Further Earnings Growth?"
              },
              {
                "id": 143043355,
                "url": "https://finnhub.io/api/news?id=9f9bbecbb02e6b9615978e684871bc2e9e9b887dcad127dc6fb88c78b0194c36",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories (IDXX) drew fresh attention after Jefferies reiterated its Buy rating while cutting two animal health peers on pricing concerns, and highlighted diagnostics as relatively better insulated within the broader veterinary and livestock market. Recent trading has shifted in IDEXX Laboratories' favor, with a 7 day share price return of 5.47% and a 30 day share price gain of 8.27%. However, the year to date share price return is down 16.73% and the 1 year total shareholder return...",
                "category": "company",
                "datetime": 1792559913,
                "headline": "IDEXX Laboratories (IDXX) Rebounds On Jefferies Support, Is It Still 20% Undervalued?"
              },
              {
                "id": 143030375,
                "url": "https://finnhub.io/api/news?id=c66e14501297d38ad36c19a7e5b21ea10a84d482bf5db203603f702a06356773",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1792509003,
                "headline": "Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 143009764,
                "url": "https://finnhub.io/api/news?id=72da0b764c862860b5f47527ae0e61d489775b1df261624cb17e4aa4d8ad3c8f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Idexx (IDXX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
                "category": "company",
                "datetime": 1792422003,
                "headline": "Idexx (IDXX) Moves to Buy: Rationale Behind the Upgrade"
              }
            ],
            "raw_source": [
              {
                "id": 143238538,
                "url": "https://finnhub.io/api/news?id=750d30d484ade3a1e8159854b38c44d28a178a1afa8577adc1f3962168ef30fc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Aurora Cannabis heads into Q2 earnings with revenues expected to fall 20.1%, as market exits and reimbursement cuts weigh on results while international medical cannabis markets offer support.",
                "category": "company",
                "datetime": 1793114040,
                "headline": "ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus"
              },
              {
                "id": 143201697,
                "url": "https://finnhub.io/api/news?id=5a66f3c8a41c7c96ee898feddb2e9473753767632cd20bd6fe4813ae2519291f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "For questions about this article or underlying research, email help@trefis.com.",
                "category": "company",
                "datetime": 1793034972,
                "headline": "Can Zoetis Stock Jump 30%?"
              },
              {
                "id": 143202807,
                "url": "https://finnhub.io/api/news?id=7d660da91e5e36c50c0862709fd06d2cc285ddbc13c635d959bafa56d1e4869b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "DXCM Q3 earnings are likely to benefit from CGM adoption, G7 15 Day uptake and wider reimbursement amid tougher international comparisons.",
                "category": "company",
                "datetime": 1793033940,
                "headline": "DexCom Gears Up to Report Q3 Results: How to Play the Stock?"
              },
              {
                "id": 143200557,
                "url": "https://finnhub.io/api/news?id=d0d6070828cacd9dce680ca92936ee51472dc89887d81dfe1b2914264de18274",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "BAX's Q3 revenues may rise, but earnings may fall amid tariffs, manufacturing costs and infusion pump challenges. Will stronger demand offset pressures?",
                "category": "company",
                "datetime": 1793024580,
                "headline": "Will Baxter's Q3 Earnings Show Progress Despite Cost Pressures?"
              },
              {
                "id": 143200587,
                "url": "https://finnhub.io/api/news?id=1d076e9f7ff5612c6f6c0677e3b7890c25cfe4d5a892792ddac12c66fb450509",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1793019612,
                "headline": "Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 143133767,
                "url": "https://finnhub.io/api/news?id=32f6b2e8673e47899d273a67b23a2144259be1a6fb9adac7f2491f6314a01888",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "RMD heads into Q1 fiscal 2027 earnings with sleep device demand and new product launches supporting growth, while MatrixCare's divestiture weighs on revenues.",
                "category": "company",
                "datetime": 1792756500,
                "headline": "ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock?"
              },
              {
                "id": 143133781,
                "url": "https://finnhub.io/api/news?id=04d51346696b34e124e6afcf725f494ecd3ddfa35bc03eef29bcd399ae56011d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDXX heads into Q3 earnings with expected revenue and EPS growth, fueled by CAG Diagnostics momentum, higher testing volumes and software gains.",
                "category": "company",
                "datetime": 1792754340,
                "headline": "Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings"
              },
              {
                "id": 143104276,
                "url": "https://finnhub.io/api/news?id=12dec2da51e73e3d58d1875772428842d2100dc7e0c4ca0a1127faa2465f0df9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Is IDXX a good stock to buy? We came across a bullish thesis on IDEXX Laboratories, Inc. on Astute Optics – US’s Substack. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.’s share was trading at $553.48 as of October 21st 2026. IDXX’s trailing and forward P/E were 36.65 and 31.45 respectively […]",
                "category": "company",
                "datetime": 1792700301,
                "headline": "IDEXX Laboratories (IDXX) vs. ZTS and NEOG: Can Raised Guidance and Product Expansion Drive Further Earnings Growth?"
              },
              {
                "id": 143103211,
                "url": "https://finnhub.io/api/news?id=1935ce0d382d5a96d0639ecfa8bb0d39b3f1afd2349b22a8dd6369fbc3b4932c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Long-term stock market performance depends on more than economic growth, interest rates, and corporate earnings. Broader trends that develop over many years can also create investment opportunities, particularly for companies positioned to benefit from lasting changes in consumer behavior and business spending. These trends may become especially important as the pace of economic growth slows. With investors facing a more challenging environment, Goldman Sachs Chief U.S. Equity Strategist Ben Sni",
                "category": "company",
                "datetime": 1792691280,
                "headline": "Goldman Sachs Sees a Shift in the Stock Market — and Names 2 Stocks to Buy Now"
              },
              {
                "id": 143100621,
                "url": "https://finnhub.io/api/news?id=a8698f0719f543a45a3043e24bc1b0a6f9596a76ec9c66d43eab7060c8670246",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Edwards Lifesciences' TMTT and TAVR growth, strong clinical evidence and solid balance sheet support expansion, but tariffs and currency headwinds threaten margins.",
                "category": "company",
                "datetime": 1792669680,
                "headline": "Is This the Right Time to Hold EW Stock in Your Portfolio?"
              },
              {
                "id": 143100619,
                "url": "https://finnhub.io/api/news?id=5ed05253eec32aec0ac36c4336ca838cd46c85ff897c028216cb57ab1e78e489",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Illumina's Q3 results may benefit from strong clinical demand, NovaSeq X adoption, instrument placements and innovations despite persistent weakness in research markets.",
                "category": "company",
                "datetime": 1792669500,
                "headline": "ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance"
              },
              {
                "id": 143078183,
                "url": "https://finnhub.io/api/news?id=cc9bf5aab1152f8234329b7d6bdc8eb1927731b98d294b46d37df65a0fc610ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "For questions about this article or underlying research, email help@trefis.com.",
                "category": "company",
                "datetime": 1792640090,
                "headline": "How Unusual Is Zoetis's Latest Sales Growth?"
              },
              {
                "id": 143067801,
                "url": "https://finnhub.io/api/news?id=5c53b2916e431e5fa66c05efc1be494194c5a3ba0eef87a9b5194976543a0ca5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Boston Scientific's Q3 results hinge on MedSurg strength in Endoscopy and Neuromodulation, as Cardiovascular faces competitive pressures and softer sales.",
                "category": "company",
                "datetime": 1792585560,
                "headline": "BSX Set to Report Q3 Earnings: Will MedSurg Strength Aid Performance?"
              },
              {
                "id": 143067778,
                "url": "https://finnhub.io/api/news?id=ebe0cb44f595c54c87e026cbb2cdb728d01f270e97c1f7cb2dbe1f915866b002",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "ECL gears up for Q3 earnings with strong growth prospects in AI infrastructure, Life Sciences and pricing, but rising costs could pressure margins.",
                "category": "company",
                "datetime": 1792584420,
                "headline": "Ecolab Gears Up to Report Q3 Results: How to Play the Stock?"
              },
              {
                "id": 143043355,
                "url": "https://finnhub.io/api/news?id=9f9bbecbb02e6b9615978e684871bc2e9e9b887dcad127dc6fb88c78b0194c36",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories (IDXX) drew fresh attention after Jefferies reiterated its Buy rating while cutting two animal health peers on pricing concerns, and highlighted diagnostics as relatively better insulated within the broader veterinary and livestock market. Recent trading has shifted in IDEXX Laboratories' favor, with a 7 day share price return of 5.47% and a 30 day share price gain of 8.27%. However, the year to date share price return is down 16.73% and the 1 year total shareholder return...",
                "category": "company",
                "datetime": 1792559913,
                "headline": "IDEXX Laboratories (IDXX) Rebounds On Jefferies Support, Is It Still 20% Undervalued?"
              },
              {
                "id": 143030375,
                "url": "https://finnhub.io/api/news?id=c66e14501297d38ad36c19a7e5b21ea10a84d482bf5db203603f702a06356773",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1792509003,
                "headline": "Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 143026299,
                "url": "https://finnhub.io/api/news?id=047a8f7b40a7ad7ea4826c6ad830d435d35a328225cc31a852577bb1e91bb2c2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Investing.com -- Jefferies downgraded Zoetis and Elanco to Hold from Buy on Tuesday, warning that pricing power in animal health is at risk. The firm reiterated its Buy rating on IDEXX Laboratories.",
                "category": "company",
                "datetime": 1792501571,
                "headline": "Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX"
              },
              {
                "id": 143028979,
                "url": "https://finnhub.io/api/news?id=7da8a33ea337352ee127c4aa499bdbd7395979da6fc7615be9b0a3e376310dbd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "The $3.40 billion fund sold $340.3 million of stock, cutting all 48 positions and adding none.",
                "category": "company",
                "datetime": 1792494294,
                "headline": "What iShares U.S. Medical Devices ETF (IHI) Sold: Abbott Leads on Friday"
              },
              {
                "id": 143009764,
                "url": "https://finnhub.io/api/news?id=72da0b764c862860b5f47527ae0e61d489775b1df261624cb17e4aa4d8ad3c8f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Idexx (IDXX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
                "category": "company",
                "datetime": 1792422003,
                "headline": "Idexx (IDXX) Moves to Buy: Rationale Behind the Upgrade"
              },
              {
                "id": 142959207,
                "url": "https://finnhub.io/api/news?id=71b17cbd30cf9aa4ef3c77c0f458131845b037c6290603b9f3dd4fe992b04de2",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "IDXX",
                "summary": "S&P 500 top movers today: HONA, EOG, EXE, NI, EQT, MSI, BKR, KMI, IDXX and SLB gained, while TWLO, MRNA, SMCI, CRWD, FTNT, DDOG, PLTR, COHR, FLEX and STX declined.",
                "category": "company",
                "datetime": 1792168603,
                "headline": "S&P 500 Top Movers Today: HONA Tops Gainers, TWLO Tops Decliners"
              },
              {
                "id": 142960996,
                "url": "https://finnhub.io/api/news?id=265b302afede83b1c08e059b0ef308f526a917a77812946f139e524f916bf006",
                "image": "",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "JP Morgan  analyst Chris Schott   maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $775 to $750.",
                "category": "company",
                "datetime": 1792151757,
                "headline": "JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750"
              },
              {
                "id": 142921544,
                "url": "https://finnhub.io/api/news?id=365623aeec17f10dbfe574f9c669d348f2a52d20204521f065fbb56c98328562",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "IDEXX Laboratories is set to report its Q3 results next month, with analysts expecting single-digit year-over-year EPS growth.",
                "category": "company",
                "datetime": 1792068717,
                "headline": "IDEXX Laboratories’ Q3 2026 Earnings: What to Expect"
              },
              {
                "id": 139933529,
                "url": "https://finnhub.io/api/news?id=3f89e8879d586e5cd629005d198da398df5b90ad7a78af13079c92adb0c779d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1791812513,
                "headline": "Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls"
              },
              {
                "id": 142819706,
                "url": "https://finnhub.io/api/news?id=cc1ff34d58837e51a265b6278467a9da2dd474867ea7e4040fe5732ed39f01b8",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/12/Robinhood-Mobile-App-On-Screen-Smartphon.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "Analysts initiated coverage on ASBH, QNRX, AXGN and HOOD with bullish ratings and targets; IDXX received a Sector Weight rating.",
                "category": "company",
                "datetime": 1791791688,
                "headline": "This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday"
              },
              {
                "id": 142819707,
                "url": "https://finnhub.io/api/news?id=cade727d44bb2e4408c33d27a15d10d0e384f66608c8139e4dc2ebd6fddb9743",
                "image": "",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "Keybanc  analyst Steve Dechert    initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a Sector Weight rating.",
                "category": "company",
                "datetime": 1791789508,
                "headline": "Keybanc Initiates Coverage On IDEXX Laboratories with Sector Weight Rating"
              },
              {
                "id": 142662618,
                "url": "https://finnhub.io/api/news?id=d78ffd39021735e4739cfbbd4e7ce2c89bcdbad94ff4f003fc44637d8d221831",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/05/Nasdaq-Inscription-Next-To-Us-Dollars--T.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IDXX",
                "summary": "The Nasdaq 100 trades at records Monday, yet 55 of its 101 stocks sit below their 50-day average. QQQ has beaten equal-weight QQQE by 8% since late July.",
                "category": "company",
                "datetime": 1791212429,
                "headline": "Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average"
              },
              {
                "id": 142559981,
                "url": "https://finnhub.io/api/news?id=19f1aa29e886104e99e60b8def94b7c6e38f4f69d0428789c998ba695d65c549",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "WESTBROOK, Maine, October 01, 2026--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 third quarter financial results for Monday, November 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.",
                "category": "company",
                "datetime": 1790868600,
                "headline": "IDEXX Laboratories to Release 2026 Third Quarter Financial Results"
              },
              {
                "id": 142515334,
                "url": "https://finnhub.io/api/news?id=4b012e2593a8595f08868b3545d7cb532717d67e4d374a98518508eed35724da",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IDXX",
                "summary": "Chicago Pacific Founders (\"CPF\") today announced the exit of its investment in CoVetAI Inc. (\"CoVet\") following the company's acquisition by IDEXX Laboratories, Inc. (NASDAQ: IDXX). Financial terms were not disclosed.",
                "category": "company",
                "datetime": 1790773200,
                "headline": "Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 5,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.9,
            "source_article_count": 28,
            "discarded_article_count": 23
          },
          "sentimentPoints": 8
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 21.8,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1.5,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日3日)；站上MA50；升放量(近10日4日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 515890,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 522370,
              "avg_vol_20": 525395,
              "avg_vol_30": 515890,
              "range_pct_10": 0.10159469042316266,
              "range_pct_20": 0.12575499331848555,
              "range_pct_30": 0.12575499331848555,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 4,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.012560817228479,
              "dist_to_20d_high": 0.018364669873196328,
              "down_shrink_days": 3,
              "breakout_level_20d": 571.75,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.807877983547462
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.224124721603564,
              "turnoverUsdM": 273.96352375,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.IDXX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 536.2842,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.4,
            "take_profit_price": 589.3125,
            "target_multiplier": 1.9,
            "technical_strength": 1.75,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.448249443207128,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 12.4829,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.22
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "強勢區",
      "score": 10,
      "value": 87.16
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1109
    },
    "kdj": {
      "d": 84.14,
      "j": 81.21,
      "k": 83.16,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 63.34
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 1920369,
      "recentSlope": 86156.9,
      "previousSlope": 143390
    },
    "rsi": 74.69,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 524.7886,
      "position": "SAR喺價下",
      "distancePct": 6.5,
      "previousTrend": "上升"
    },
    "ma50": 533.6936,
    "macd": {
      "macd": 10.030663463998394,
      "trend": "強烈看漲",
      "signal": 5.890833995083664,
      "histogram": 4.13982946891473
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 536.0491,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 13
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.94,
      "score": 4,
      "avgVolume": 517357,
      "currentVolume": 488131
    },
    "derived": {
      "ma20": 537.2615,
      "ma50": 533.6936,
      "prevClose": 570.21,
      "avgVolume10": 526643,
      "avgVolume20": 517357,
      "changePercent": -1.57,
      "avgVolumeForScore": 517357
    },
    "ma_cross": {
      "ma20": 537.2615,
      "ma50": 533.6936,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 535.871,
      "prevMa50": 533.3904,
      "spreadPct": 0.67,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 495.552,
      "upper": 578.971,
      "position": "上半部"
    },
    "rsi_short": 56.05,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.94
    }
  }
}

{
  "close": 561.25,
  "volume": 488131,
  "changePercent": -1.57
}